ZANATTA, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.027
AS - Asia 2.739
EU - Europa 1.702
SA - Sud America 696
AF - Africa 616
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 24
Totale 9.873
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.669
SG - Singapore 1.048
BR - Brasile 454
IT - Italia 445
CN - Cina 404
HK - Hong Kong 346
VN - Vietnam 206
DE - Germania 185
FI - Finlandia 104
PL - Polonia 85
NL - Olanda 84
GB - Regno Unito 70
RU - Federazione Russa 68
IN - India 64
FR - Francia 63
SE - Svezia 57
JP - Giappone 50
AR - Argentina 49
AT - Austria 42
TR - Turchia 38
CA - Canada 36
KR - Corea 35
EC - Ecuador 34
ES - Italia 34
BJ - Benin 33
MX - Messico 32
CO - Colombia 31
IQ - Iraq 30
DO - Repubblica Dominicana 29
PY - Paraguay 28
ID - Indonesia 27
IE - Irlanda 27
ZA - Sudafrica 27
AZ - Azerbaigian 26
BG - Bulgaria 26
KH - Cambogia 26
SO - Somalia 26
BE - Belgio 25
UZ - Uzbekistan 25
IR - Iran 24
AE - Emirati Arabi Uniti 23
AM - Armenia 23
LU - Lussemburgo 23
SA - Arabia Saudita 23
GR - Grecia 22
PA - Panama 22
IL - Israele 21
JM - Giamaica 21
KG - Kirghizistan 21
ME - Montenegro 21
UA - Ucraina 21
AL - Albania 20
GA - Gabon 20
RO - Romania 20
UG - Uganda 20
BD - Bangladesh 19
CZ - Repubblica Ceca 19
GT - Guatemala 19
JO - Giordania 19
MK - Macedonia 19
MY - Malesia 19
NI - Nicaragua 19
PS - Palestinian Territory 19
RW - Ruanda 19
SN - Senegal 19
TN - Tunisia 19
BS - Bahamas 18
KE - Kenya 18
UY - Uruguay 18
AU - Australia 17
CH - Svizzera 17
LB - Libano 17
MG - Madagascar 17
NO - Norvegia 17
PK - Pakistan 17
TT - Trinidad e Tobago 17
TZ - Tanzania 17
VE - Venezuela 17
BA - Bosnia-Erzegovina 16
BF - Burkina Faso 16
BO - Bolivia 16
BW - Botswana 16
CL - Cile 16
HU - Ungheria 16
MA - Marocco 16
ML - Mali 16
PE - Perù 16
PH - Filippine 16
SI - Slovenia 16
ZW - Zimbabwe 16
AO - Angola 15
CM - Camerun 15
CV - Capo Verde 15
DK - Danimarca 15
GF - Guiana Francese 15
GH - Ghana 15
LC - Santa Lucia 15
LY - Libia 15
NC - Nuova Caledonia 15
SK - Slovacchia (Repubblica Slovacca) 15
Totale 9.191
Salva come PNG Salva come JPEG
Città #
Singapore 593
Ashburn 541
Fairfield 405
Hong Kong 334
Chandler 281
Woodbridge 175
Houston 140
Cambridge 139
Beijing 133
Santa Clara 127
Seattle 126
Ann Arbor 105
Wilmington 104
Los Angeles 101
Boardman 96
Munich 96
Chicago 83
Padova 81
Ho Chi Minh City 80
San Diego 58
Hefei 51
New York 50
Hanoi 49
Helsinki 48
Bytom 47
Salt Lake City 45
São Paulo 43
Buffalo 39
Milan 39
Medford 35
Princeton 35
Cotonou 31
Tokyo 29
Turku 28
Des Moines 26
Warsaw 25
Baku 24
Phnom Penh 24
Stockholm 23
Tampa 23
Tashkent 23
Elk Grove Village 22
Rio de Janeiro 22
Yerevan 22
Seoul 21
Dublin 20
Kampala 20
Nuremberg 20
Phoenix 20
Sofia 20
Vienna 20
Amman 19
Bishkek 19
Managua 19
Panama City 19
Athens 18
Brooklyn 18
Dakar 18
Libreville 18
Dallas 17
Kigali 17
Montevideo 17
Nairobi 17
Rome 17
Antananarivo 16
London 16
Nassau 16
Podgorica 16
Castries 15
Hargeisa 15
Johannesburg 15
Luxembourg 15
Montreal 15
Naples 15
Atlanta 14
Bengaluru 14
Dili 14
Dushanbe 14
Harare 14
Istanbul 14
Lappeenranta 14
Noumea 14
Amsterdam 13
Bamako 13
Dar es Salaam 13
Falkenstein 13
Kingston 13
Nouakchott 13
Praia 13
Cayenne 12
Ljubljana 12
Reykjavik 12
San José 12
Santo Domingo 12
Abidjan 11
Baghdad 11
Bologna 11
Khartoum 11
Lima 11
Luanda 11
Totale 5.458
Salva come PNG Salva come JPEG
Nome #
MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives 300
Therapy of scleroderma renal crisis: State of the art 213
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients 208
Evaluation of right ventricular function performed by 3d-echocardiography in scleroderma patients 206
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database 201
Mud-bath treatment of seronegative spondyloarthritis: experience at the Euganean Thermal Area 200
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 189
Anti-MDA5 dermatomyositis: an update from bench to bedside 186
Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies 184
Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus 180
Balneotherapy in chronic inflammatory rheumatic diseases—a narrative review 179
Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association 175
IL-12 and IL-23/Th17 axis in systemic lupus erythematosus 172
Belimumab: a step forward in the treatment of systemic lupus erythematosus 172
The power of the EUSTAR cohort: key findings to date and implicationsfor management of systemic sclerosis patients 168
Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment 167
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 165
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 162
Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies. 162
How I treat patients with systemic sclerosis in clinical practice 158
Cocaine- and Levamisole-Induced Vasculitis: Defining the Spectrum of Autoimmune Manifestations 157
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 155
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review 151
PD-1 gene rs2227981 (PD-1.5) polymorphism analysis in patients with systemic sclerosis 149
Long-term improvement in activities of daily living in women with systemic sclerosis attending to occupational therapy. 140
Inflammation and coronary microvascular dysfunction in autoimmune rheumatic diseases 138
Skin ulcers in systemic sclerosis: correlation with clinical phenotype in a monocentric cohort from the north-east of Italy 137
Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study. 136
Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis 136
Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management 136
Circulating extracellular vesicles and small non-coding RNAs cargo in idiopathic inflammatory myopathies reveal differences across myositis subsets 133
Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates 130
Size-Exclusion Chromatography Combined with Ultrafiltration Efficiently Isolates Extracellular Vesicles from Human Blood Samples in Health and Disease 118
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort 118
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 117
Covid-19 and rheumatic autoimmune systemic diseases: Role of pre-existing lung involvement and ongoing treatments 116
Coronary microvascular dysfunction in autoimmune rheumatic diseases: beyond coronary flow velocity reserve 115
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study 112
Effects of mud-bath applications on synovial inflammation evaluated by contrasted-enhanced ultrasound (CEUS) in patients with psoriatic arthritis 112
Prevalence of diaphragm dysfunction in patients with interstitial lung disease (ILD): The role of diaphragmatic ultrasound 109
The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis 108
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 107
NITRIC OXIDE DIFFUSION IN PATIENTS WITH SSc 107
Pseudotumoral calcinosis in systemic sclerosis: Data from systematic literature review and case series from two referral centres 107
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort 107
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database 104
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies 104
Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis 101
Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies 100
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 100
Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review 100
Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse Clinical Outcome in Systemic Sclerosis 99
Systemic sclerosis sine scleroderma in children 97
Update on Rheumatic Diseases in Clinical Practice 96
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time? 94
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 94
Evaluation of extracellular vesicles as potential biomarkers of myositis 91
The role of plasma exchange in the management of autoimmune disorders 90
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 89
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 88
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort 87
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 86
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension 83
Capillary Desertification and Refractory Digital Ulcers in Systemic Sclerosis 80
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition 78
Should we use nintedanib as early therapy in patients with SSc-ILD? 77
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual 77
Hypovitaminosis D in an hospitalized old population of Western Friuli 77
Systemic sclerosis sine scleroderma is more aggressive in children than in adults 75
Systemic sclerosis: Recent insight in clinical management 75
The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease 67
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 66
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 63
Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study 61
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort 56
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 53
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort 52
Scleroderma renal crisis: Case reports and update on critical issues 52
Primordial and primary prevention in rheumatological diseases: The time has come 51
Human epididymis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathies 51
Systemic sclerosis: state of the art on clinical practice guidelines 50
Cardiovascular involvement as a clue for diagnosis of Juvenile Systemic Sclerosis sine scleroderma 48
Does body composition matter in patients with systemic sclerosis? 45
Late Skin Fibrosis in Systemic Sclerosis: A Study from the EUSTAR Cohort 45
The Influence of Dietary Intervention in Connective Tissue Diseases: Evidence from Randomized Clinical Trials 45
Predictors of Persistent Disease Activity and Damage in Systemic Sclerosis: Associations With Mortality in a Single-Center Cohort Study 22
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort 16
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort 14
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database 13
Milk of calcium in scleromyositis 7
Totale 10.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.195
article - articoli 33.556
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021452 0 0 0 0 0 22 12 48 59 29 43 239
2021/2022504 14 35 50 29 13 70 40 41 25 40 37 110
2022/2023556 88 55 18 82 78 72 7 35 65 19 20 17
2023/2024568 21 57 66 51 50 64 42 27 35 30 57 68
2024/20252.219 30 170 89 118 213 95 185 183 126 101 383 526
2025/20264.969 506 659 1.160 1.499 960 185 0 0 0 0 0 0
Totale 10.017